Tom Budszus

London

Slot Editor at Alliance News

Alliance News slot editor

Articles

AstraZeneca says Enhertu slashes disease progression risk in cancer

6 days ago | ca.marketscreener.com | Tom Budszus

Published on 2025-06-02 at 09:26 (Alliance News) - AstraZeneca PLC on Monday said Enhertu reduced the risk of disease progression in a form of breast cancer. The Cambridge, England-based pharmaceutical company said Enhertu plus pertuzumab reduced the risk of disease progression in HER2-positive metastatic breast cancer by 44%, when compared to taxane, trastuzumab & pertuzumab or THP. This was as a first-line treatment for patients with this form of cancer.
ME Group International celebrates laundry-boosted trading momentum

6 days ago | marketscreener.com | Tom Budszus

Published on 06/02/2025 at 04:08 (Alliance News) - ME Group International PLC on Monday said it continues to expect pretax profit for the current financial year to beat last year's, as "record trading momentum" continued in the first half. In a trading update, the Surrey, England-based vending machine operator said pretax profit increased by around 14% on-year and revenue by around 2% in the six months that ended April 30, "driven by the strong continued performance in our laundry business".
AstraZeneca hails Imfinzi results on early stage gastric cancer

6 days ago | marketscreener.com | Tom Budszus

Published on 06/02/2025 at 01:46 (Alliance News) - AstraZeneca on Sunday said its monoclonal antibody Imfinzi in combination with standard of care chemotherapy demonstrated significant and meaningful improvement in event-free survival in early stage gastric cancer, compared to chemotherapy alone.
AstraZeneca says Enhertu slashes disease progression risk in cancer

6 days ago | morningstar.co.uk | Tom Budszus

(Alliance News) - AstraZeneca PLC on Monday said Enhertu reduced the risk of disease progression in a form of breast cancer. The Cambridge, England-based pharmaceutical company said Enhertu plus pertuzumab reduced the risk of disease progression in HER2-positive metastatic breast cancer by 44%, when compared to taxane, trastuzumab & pertuzumab or THP. This was as a first-line treatment for patients with this form of cancer.
JPMorgan Asia Growth outperforms benchmark but interim return negative

1 week ago | marketscreener.com | Tom Budszus

Published on 05/30/2025 at 09:40 (Alliance News) - JPMorgan Asia Growth & Income Investment Trust PLC on Friday said its portfolio managers had a generally positive view on the outlook for Asian markets, despite posting a negative total return on net asset value. The investor in Asia-Pacific entities said net asset value per share was 405.3 pence as at March 31, down 3.0% from 417.9p at September 30.
M&G shares up as Dai-ichi Life aims to buy 15% stake amid partnership

1 week ago | marketscreener.com | Tom Budszus

Published on 05/30/2025 at 04:54 (Alliance News) - M&G PLC on Friday said it entered a new long-term strategic partnership with Japanese life insurer Dai-ichi Life Holdings Inc on asset management and life insurance. The London-based asset manager will become Dai-ichi Life's preferred asset management partner in Europe, with the goal of delivering "substantial" new business flows for both companies.
GenIP shares up as secures entry into Brazilian market

1 week ago | in.marketscreener.com | Tom Budszus

GenIP PLC - generative AI analytic services provider - Secures first engagement in Brazil via a contract with a government agency. "GenIP has won a contract to deliver its AI-enhanced technology evaluation service to a government agency that is one of the country's main funders of scientific and technological research. The collaboration supports a nationally backed bioenergy initiative designed to enhance sustainable energy innovation.
Home REIT continues rent collection ahead of wind down

1 week ago | uk.marketscreener.com | Tom Budszus

(Alliance News) - Home REIT PLC on Thursday gave an update on rent collection as its managed wind down progresses. The London-based investor in the UK's social housing sector said rent collection in April was around GBP1.1 million, while it has no debt as it fully repaid loans and fees to Scottish Widows. The company said house prices continued to be resilient as some regions and sub-sectors attracted increased investment, but noted that economic uncertainties persisted.
CT UK Capital & Income Investment ups dividend despite underperforming

1 week ago | marketscreener.com | Tom Budszus

Published on 05/29/2025 at 07:12 (Alliance News) - CT UK Capital & Income Investment Trust PLC on Thursday highlighted "very considerable uncertainty" for the current economic times, for which it is difficult to find a parallel. CT UK Capital said net asset value per share was 331.45 pence each on March 31, down 3.6% from 343.84p on September 30, 2024.
Helios Underwriting says best years of insurance cycle ahead

1 week ago | uk.marketscreener.com | Tom Budszus

Published on 29/05/2025 at 11:50 (Alliance News) - Helios Underwriting PLC on Thursday reported a higher net asset value as it expects the best years of the insurance cycle to be ahead of it. The investment vehicle that provides participation in the Lloyd's of London insurance market said net asset value per share was GBP2.43 as at December 31, up 11% from GBP2.19 a year prior. Pretax profit fell 42% to GBP20.9 million in 2024 from GBP36.3 million in 2023.